DNA and microbiome testing provide new options to tackle Canada’s health problems.
In Canada, preventable chronic diseases are among the leading causes of death and cost billions in healthcare every year. And when healthcare is universal, that also means a big chunk of taxes paid by individuals and companies from hard-earned money.
Many of these conditions can’t be cured (thus “chronic”), only managed, and are caused by a combination of factors, including lifestyle, gut microbial health and genetic predisposition. New technology, like microbiome and DNA testing, can assess for risk factors and help prevent many chronic diseases.
Tech to solve chronic disease
This symbiotic ecosystem of bacteria lives in the colon. Weighing in at 2-3 kg, the microbiome performs essential functions for the digestive system and overall health. When it is unbalanced, a problem called dysbiosis, it can cause inflammation and contribute to disease.
Anna, from our Microbiome Research dpt, presenting results of probiotic research
In addition to digestive conditions, gut bacteria, lifestyle and genetic markers in a person’s DNA can enhance risks of many chronic diseases seemingly unrelated to the colon, including metabolic illnesses like obesity, diabetes type II and cardiovascular disease.
These diseases are among the deadliest in Canada.
How it works and how we work
Nearly two-thirds of Canadians suffer from obesity and overweight, a primary factor in the growing epidemic of diabetes type 2 that is a precursor for cardiovascular disease, responsible for about 29% of all deaths. Technology like ours has the potential to change this health landscape, and we are excited to contribute.
Swift technological advances like Atlas Biomed microbiome and DNA testing and interpretation systems take time to be adopted by healthcare systems. Fortunately, the Canadian government, like the EU and UK, has made provisions for people to take control of their health during such periods.
Their sample collection kits meet all standards required for medical-grade laboratory analysis around the world. That’s why we use their kits to collect your spit and stool in 11 different European countries, and now their home country, Canada too!
Building bridges to a better future
Atlas Biomed participates in many research projects tackling important questions, like how gut microbial affects immunotherapy treatment for cancer patients, the effects of specific probiotic strains of bacteria on IBS, IBD and even Parkinson’s. We also use our technology to support research into the potential benefits of traditional fermented and cultured foods.
We also believe in transparency and best practice when it comes to people’s genetic and private information. That’s why every user owns the rights to their data, we don’t sell it to anyone.
We apply the strictest standards and most advanced data protection protocols to protect our customers, who are free to request the removal of their data and the destruction of their samples at any time.
These are the principles, ethics and drive by which our company abides. They're coming to Canada with us too, hand-in-hand with our Atlas Biomed DNA and Microbiome Tests.